Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Levalbuterol vs Albuterol in Asthma
NCT00073827Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- May 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levalbuterol in asthma (3 arms), sponsored by Sumitomo Pharma America. Primary endpoint: percent change in FEV1 from visit predose averaged over the 8-week double-blind period. Started May 2002; status: completed.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00073827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073827.